T. Rowe Price Associates’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.89M Buy
36,823
+7,348
+25% +$1.77M ﹤0.01% 1134
2025
Q1
$7.18M Buy
29,475
+331
+1% +$80.6K ﹤0.01% 1177
2024
Q4
$9.58M Buy
29,144
+1,524
+6% +$501K ﹤0.01% 1158
2024
Q3
$9.24M Sell
27,620
-17,730
-39% -$5.93M ﹤0.01% 1151
2024
Q2
$12.4M Buy
45,350
+768
+2% +$210K ﹤0.01% 1070
2024
Q1
$15.4M Buy
44,582
+748
+2% +$259K ﹤0.01% 1033
2023
Q4
$14.2M Sell
43,834
-2,113
-5% -$682K ﹤0.01% 1030
2023
Q3
$16.5M Sell
45,947
-5,175
-10% -$1.86M ﹤0.01% 959
2023
Q2
$19.4M Sell
51,122
-350
-0.7% -$133K ﹤0.01% 942
2023
Q1
$24.7M Sell
51,472
-4,356
-8% -$2.09M ﹤0.01% 865
2022
Q4
$23.5M Sell
55,828
-11,450
-17% -$4.81M ﹤0.01% 865
2022
Q3
$28.1M Buy
67,278
+339
+0.5% +$141K ﹤0.01% 805
2022
Q2
$33.1M Sell
66,939
-3,445
-5% -$1.71M ﹤0.01% 1010
2022
Q1
$39.6M Sell
70,384
-3,073
-4% -$1.73M ﹤0.01% 1050
2021
Q4
$55.5M Sell
73,457
-749
-1% -$566K 0.01% 963
2021
Q3
$55.4M Sell
74,206
-7,785
-9% -$5.81M 0.01% 971
2021
Q2
$52.8M Buy
81,991
+9,321
+13% +$6.01M ﹤0.01% 1006
2021
Q1
$41.5M Buy
72,670
+36,163
+99% +$20.7M ﹤0.01% 1065
2020
Q4
$21.3M Sell
36,507
-56,411
-61% -$32.9M ﹤0.01% 1213
2020
Q3
$47.9M Sell
92,918
-19,413
-17% -$10M 0.01% 886
2020
Q2
$50.7M Sell
112,331
-43,405
-28% -$19.6M 0.01% 849
2020
Q1
$54.6M Buy
155,736
+529
+0.3% +$185K 0.01% 754
2019
Q4
$57.4M Buy
155,207
+238
+0.2% +$88.1K 0.01% 867
2019
Q3
$51.6M Sell
154,969
-2,172
-1% -$723K 0.01% 863
2019
Q2
$49.1M Sell
157,141
-860
-0.5% -$269K 0.01% 899
2019
Q1
$48.3M Sell
158,001
-1,886
-1% -$577K 0.01% 892
2018
Q4
$37.1M Buy
159,887
+8,983
+6% +$2.09M 0.01% 934
2018
Q3
$47.2M Buy
150,904
+6,065
+4% +$1.9M 0.01% 935
2018
Q2
$41.8M Buy
144,839
+5,690
+4% +$1.64M 0.01% 957
2018
Q1
$34.8M Buy
139,149
+253
+0.2% +$63.3K 0.01% 998
2017
Q4
$33.2M Buy
138,896
+1,145
+0.8% +$273K 0.01% 1016
2017
Q3
$30.6M Buy
137,751
+8,352
+6% +$1.86M 0.01% 1031
2017
Q2
$29.3M Sell
129,399
-1,975
-2% -$447K 0.01% 1030
2017
Q1
$26.2M Buy
131,374
+15,235
+13% +$3.04M ﹤0.01% 1053
2016
Q4
$21.2M Sell
116,139
-2,898
-2% -$528K ﹤0.01% 1120
2016
Q3
$19.5M Buy
119,037
+4,800
+4% +$786K ﹤0.01% 1139
2016
Q2
$16.3M Sell
114,237
-1,515
-1% -$217K ﹤0.01% 1157
2016
Q1
$15.8M Sell
115,752
-6,080
-5% -$831K ﹤0.01% 1155
2015
Q4
$16.9M Buy
121,832
+8,242
+7% +$1.14M ﹤0.01% 1136
2015
Q3
$15.3M Buy
113,590
+23,100
+26% +$3.1M ﹤0.01% 1179
2015
Q2
$13.6M Buy
90,490
+38,900
+75% +$5.86M ﹤0.01% 1257
2015
Q1
$6.97M Buy
51,590
+4,300
+9% +$581K ﹤0.01% 1418
2014
Q4
$5.7M Sell
47,290
-3,400
-7% -$410K ﹤0.01% 1440
2014
Q3
$5.75M Hold
50,690
﹤0.01% 1432
2014
Q2
$6.07M Buy
50,690
+2,400
+5% +$287K ﹤0.01% 1424
2014
Q1
$6.19M Sell
48,290
-200
-0.4% -$25.6K ﹤0.01% 1397
2013
Q4
$5.99M Sell
48,490
-600
-1% -$74.2K ﹤0.01% 1403
2013
Q3
$5.77M Sell
49,090
-600
-1% -$70.5K ﹤0.01% 1396
2013
Q2
$5.58M Buy
+49,690
New +$5.58M ﹤0.01% 1385